Pregenomic RNA as a Marker for Monitoring Disease Prognosis and Viral Relapse in Hepatitis B Patients on Long‐Term Antiviral Therapy: A Systematic Review and Meta‐Analysis
Journal of Medical Virology · 2026-03 · 98 (3)
DOI: 10.1002/jmv.70866 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Medical Virology, online erschienen am 19.03.2026. Verfasst von Jayakrishna Pamarthi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, SRM Medical College Hospital and Research Centre, Faculty of Medicine and Health Science, SRM Institute of Science and Te…. Hauptthemen laut MEDLINE: Antiviral Agents, Hepatitis B virus, Hepatitis B, Chronic, RNA, Viral. Die Arbeit nennt 98 Literaturangaben. Gefördert von: Chancellor Research Fellowship for Ph.D. from SRM MCH.
Abstract (Originalsprache)
Chronic hepatitis B virus (HBV) infection poses a significant global health burden, with long‐term antiviral therapy being the primary treatment. However, predicting disease progression and the risk of viral relapse after treatment cessation remains difficult. Serum HBV pregenomic RNA (pgRNA) has recently gained attention as a potential biomarker reflecting intrahepatic viral activity, particularly that of covalently closed circular DNA (cccDNA). This study aimed to evaluate pgRNA's clinical utility as a prognostic marker in chronic HBV (CHB) patients on long‐term therapy. A systematic literature review was conducted using PubMed and Scopus, including studies up to August 27, 2024. Selected studies assessed pgRNA in relation to disease prognosis, treatment response, and relapse. Meta‐analysis showed a significant reduction in pgRNA levels post‐treatment (mean difference: 1.64; 95% CI: 0.79–2.49), consistent with decreases in HBV DNA and HBsAg. These findings support pgRNA may serve as a promising surrogate marker for treatment prognosis and potential viral relapse in HBV patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, SRM Medical College Hospital and Research Centre, Faculty of Medicine and Health Science, SRM Institute of Science and Technology, Kattankulathur, Chengalpattu, Tamilnadu, India.
- Medical Gastroenterology, SRM Medical College Hospital and Research Centre, Faculty of Medicine and Health Science, SRM Institute of Science and Technology, Kattankulathur, Chengalpattu, Tamilnadu, India.
- Department of General Medicine, SRM Medical College Hospital and Research Centre, Faculty of Medicine and Health Science, SRM Institute of Science and Technology, Kattankulathur, Chengalpattu, Tamilnadu, India.
- Division of Medical Research, SRM Medical College Hospital and Research Centre, Faculty of Medicine and Health Science, SRM Institute of Science and Technology, Kattankulathur, Chengalpattu, Tamilnadu, India.
Förderung
- Chancellor Research Fellowship for Ph.D. from SRM MCH
Zitieren
APA
Pamarthi, J., Panneerselvam, S., Rajesh, N. A., Kumar, J. S., & Haridoss, M. (2026). Pregenomic RNA as a Marker for Monitoring Disease Prognosis and Viral Relapse in Hepatitis B Patients on Long‐Term Antiviral Therapy: A Systematic Review and Meta‐Analysis. Journal of Medical Virology, 98(3). https://doi.org/10.1002/jmv.70866
Vancouver
Pamarthi J, Panneerselvam S, Rajesh NA, Kumar JS, Haridoss M. Pregenomic RNA as a Marker for Monitoring Disease Prognosis and Viral Relapse in Hepatitis B Patients on Long‐Term Antiviral Therapy: A Systematic Review and Meta‐Analysis. Journal of Medical Virology. 2026;98(3). doi:10.1002/jmv.70866
BibTeX
@article{Pamarthi2026,
author = {Pamarthi, Jayakrishna and Panneerselvam, Sugan and Rajesh, Nanda Amarnath and Kumar, Janardanan Subramonia and Haridoss, Madhumitha},
title = {Pregenomic RNA as a Marker for Monitoring Disease Prognosis and Viral Relapse in Hepatitis B Patients on Long‐Term Antiviral Therapy: A Systematic Review and Meta‐Analysis},
journal = {Journal of Medical Virology},
year = {2026},
volume = {98},
number = {3},
doi = {10.1002/jmv.70866}
}
EUVIMED